Literature DB >> 7723618

Diurnal variation in kainate-induced AP-1 activation in rat brain: influence of glucocorticoids.

T Unlap1, R S Jope.   

Abstract

The large diurnal rhythm of circulating glucocorticoid levels was used to determine if physiological fluctuations of glucocorticoids were capable of modulating kainate-induced immediate early gene (IEG) activation, measured as AP-1 DNA binding activity, in rat brain since administered dexamethasone previously had been shown to be inhibitory. AP-1 activity in the cerebral cortex 1.5 h after kainate treatment measured at 08.00 h (4.9-fold control) was more than twice the stimulation obtained at 16.00 h (1.8-fold). These times of day are associated with reported low and high levels of circulating glucocorticoids at 08.00 and 16.00 h, respectively. To test if there was a causal relationship, kainate-induced AP-1 activity was measured at both times in adrenalectomized rats. Adrenalectomy abolished the attenuation of the response to kainate found in intact rats at 16.00 h, indicating that the diurnal fluctuations in circulating glucocorticoids contribute to modulation of IEG responses to kainate. Neither AP-1 activity in the hippocampus nor cyclic AMP response element activation in either brain region measured after kainate treatment was influenced by the time of day or by adrenalectomy. Immunoprecipitation of glucocorticoid receptors from cortical nuclear extracts co-precipitated c-Jun, indicating that the mechanism accounting for the suppression of AP-1 activity by glucocorticoids may involve direct interactions between activated glucocorticoid receptors and AP-1 constituent proteins. These results extend previous reports that administered glucocorticoids inhibit AP-1 activity by demonstrating that this occurs with endogenous glucocorticoids as a consequence of the circadian rhythm of circulating glucocorticoids and demonstrate that responses to kainate vary dependent upon the time of day.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7723618     DOI: 10.1016/0169-328x(94)00202-p

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  6 in total

1.  Plasma membrane calcium pump isoform 1 gene expression is repressed by corticosterone and stress in rat hippocampus.

Authors:  A Bhargava; O C Meijer; M F Dallman; D Pearce
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

2.  Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium.

Authors:  M B Williams; R S Jope
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 3.  Corticosteroids in the brain. Cellular and molecular actions.

Authors:  M Joëls; E Vreugdenhil
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

Review 4.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

5.  Cholinergic stimulation of AP-1 and NF kappa B transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis.

Authors:  X Li; L Song; R S Jope
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

6.  Hydrocortisone fails to abolish NF-κB1 protein nuclear translocation in deletion allele carriers of the NFKB1 promoter polymorphism (-94ins/delATTG) and is associated with increased 30-day mortality in septic shock.

Authors:  Simon T Schäfer; Sophia Gessner; André Scherag; Katharina Rump; Ulrich H Frey; Winfried Siffert; Astrid M Westendorf; Jörg Steinmann; Jürgen Peters; Michael Adamzik
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.